3 Growth Companies On KRX With Insider Ownership Up To 32%

The South Korean stock market has recently experienced volatility, with the KOSPI index dipping sharply amid mixed performances from key sectors such as financials, chemicals, and industrials. As investors navigate these fluctuating conditions, identifying growth companies with high insider ownership can provide valuable insights into potential long-term stability and confidence in the business.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.5%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.6%	52.1%
Bioneer (KOSDAQ:A064550)	17.5%	97.6%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Oscotec (KOSDAQ:A039200)	26.3%	122%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
Park Systems (KOSDAQ:A140860)	33%	35.6%
UTI (KOSDAQ:A179900)	33.1%	134.6%
HANA Micron (KOSDAQ:A067310)	21.3%	106.2%
Techwing (KOSDAQ:A089030)	18.7%	83.6%

Click here to see the full list of 87 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

People & Technology (KOSDAQ:A137400)

Simply Wall St Growth Rating: ★★★★★★

Overview: People & Technology Inc. provides coating, calendaring, slitting, automation, and other machinery services with a market cap of ₩1.31 billion.

Operations: People & Technology Inc. generates revenue primarily from machinery and industrial equipment, amounting to ₩792.60 million.

Insider Ownership: 16.5%

People & Technology exhibits strong growth potential with high insider ownership. The company's earnings grew by 50.9% over the past year and are forecast to grow 35.61% annually, significantly outpacing the South Korean market's expected growth of 29.1%. Revenue is also predicted to rise by 34.2% per year, surpassing market averages. However, shareholders have experienced dilution in the past year despite trading at a substantial discount to fair value estimates.

• Get an in-depth perspective on People & Technology's performance by reading our analyst estimates report here.
• The analysis detailed in our People & Technology valuation report hints at an deflated share price compared to its estimated value.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a bio company with a market cap of ₩16.95 trillion, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Operations: The company's revenue segment is Biotechnology, generating ₩90.79 billion.

Insider Ownership: 26.6%

ALTEOGEN demonstrates significant growth potential with high insider ownership. The company is forecast to achieve profitability within three years, with expected annual revenue growth of 64.2%, outpacing the South Korean market. Recent approval by the MFDS for its New Drug Application for Tergase® marks a pivotal milestone, enhancing its commercial prospects. Despite past shareholder dilution and share price volatility, ALTEOGEN trades at a substantial discount to fair value estimates and boasts a very high forecasted Return on Equity of 66.3%.

• Unlock comprehensive insights into our analysis of ALTEOGEN stock in this growth report.
• Our comprehensive valuation report raises the possibility that ALTEOGEN is priced higher than what may be justified by its financials.

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management with a market cap of ₩7.68 billion.

Operations: HYBE Co., Ltd. generates revenue from three primary segments: Label (₩1.28 billion), Platform (₩361.12 million), and Solution (₩1.24 billion).

Insider Ownership: 32.5%

HYBE exhibits strong growth prospects with high insider ownership. Earnings grew by 21.6% last year and are forecast to grow significantly at 42.47% annually, outpacing the South Korean market's average of 29.1%. Despite trading below fair value estimates, HYBE recently announced a share repurchase program to stabilize its stock price. However, recent earnings reports show a decline in net income and basic earnings per share compared to the previous year.

• Delve into the full analysis future growth report here for a deeper understanding of HYBE.
• Our expertly prepared valuation report HYBE implies its share price may be too high.

Make It Happen

• Explore the 87 names from our Fast Growing KRX Companies With High Insider Ownership screener here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com